Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.3400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots7.2000/ 4
- Ask / Lots7.7900/ 2
- Open / Previous Close--- / 7.3400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 10129 | 7.24 |
| 09:34 ET | 2100 | 7.26 |
| 09:36 ET | 600 | 7.215 |
| 09:38 ET | 1798 | 7.22 |
| 09:39 ET | 300 | 7.25 |
| 09:41 ET | 900 | 7.26 |
| 09:43 ET | 216 | 7.27 |
| 09:45 ET | 548 | 7.255 |
| 09:48 ET | 1528 | 7.26 |
| 09:50 ET | 3832 | 7.22 |
| 09:52 ET | 3200 | 7.2 |
| 09:54 ET | 1509 | 7.24 |
| 09:56 ET | 2400 | 7.26 |
| 09:57 ET | 949 | 7.255 |
| 09:59 ET | 573 | 7.2705 |
| 10:01 ET | 3352 | 7.31 |
| 10:03 ET | 16264 | 7.3 |
| 10:06 ET | 3365 | 7.31 |
| 10:08 ET | 3600 | 7.32 |
| 10:10 ET | 5375 | 7.35 |
| 10:12 ET | 4597 | 7.42 |
| 10:14 ET | 3093 | 7.41 |
| 10:15 ET | 3254 | 7.4 |
| 10:17 ET | 100 | 7.39 |
| 10:19 ET | 100 | 7.39 |
| 10:21 ET | 100 | 7.39 |
| 10:24 ET | 100 | 7.4 |
| 10:26 ET | 700 | 7.4 |
| 10:28 ET | 100 | 7.4 |
| 10:30 ET | 3000 | 7.4 |
| 10:32 ET | 600 | 7.405 |
| 10:33 ET | 675 | 7.39 |
| 10:35 ET | 2394 | 7.4 |
| 10:37 ET | 1200 | 7.4 |
| 10:39 ET | 2039 | 7.395 |
| 10:42 ET | 100 | 7.4 |
| 10:46 ET | 100 | 7.4 |
| 10:48 ET | 200 | 7.39 |
| 10:50 ET | 200 | 7.3815 |
| 10:51 ET | 200 | 7.39 |
| 10:53 ET | 3132 | 7.39 |
| 10:55 ET | 583 | 7.375 |
| 10:57 ET | 1001 | 7.4 |
| 11:00 ET | 330 | 7.41 |
| 11:02 ET | 500 | 7.4 |
| 11:04 ET | 895 | 7.38 |
| 11:06 ET | 1500 | 7.3785 |
| 11:08 ET | 600 | 7.41 |
| 11:09 ET | 1777 | 7.41 |
| 11:11 ET | 600 | 7.41 |
| 11:13 ET | 100 | 7.42 |
| 11:15 ET | 2515 | 7.4 |
| 11:18 ET | 1294 | 7.38 |
| 11:20 ET | 100 | 7.38 |
| 11:22 ET | 683 | 7.375 |
| 11:24 ET | 2611 | 7.385 |
| 11:27 ET | 3016 | 7.38 |
| 11:31 ET | 100 | 7.38 |
| 11:33 ET | 300 | 7.38 |
| 11:38 ET | 400 | 7.38 |
| 11:40 ET | 500 | 7.38 |
| 11:42 ET | 700 | 7.385 |
| 11:44 ET | 300 | 7.385 |
| 11:45 ET | 1100 | 7.39 |
| 11:47 ET | 2350 | 7.4 |
| 11:49 ET | 200 | 7.4 |
| 11:51 ET | 802 | 7.39 |
| 11:54 ET | 100 | 7.39 |
| 11:56 ET | 1104 | 7.38 |
| 11:58 ET | 400 | 7.385 |
| 12:00 ET | 647 | 7.385 |
| 12:02 ET | 265 | 7.385 |
| 12:03 ET | 10532 | 7.39 |
| 12:05 ET | 2057 | 7.3782 |
| 12:07 ET | 300 | 7.38 |
| 12:09 ET | 200 | 7.37 |
| 12:12 ET | 930 | 7.365 |
| 12:14 ET | 300 | 7.37 |
| 12:16 ET | 400 | 7.375 |
| 12:21 ET | 194 | 7.37 |
| 12:25 ET | 407 | 7.37 |
| 12:27 ET | 300 | 7.37 |
| 12:30 ET | 4520 | 7.375 |
| 12:32 ET | 5066 | 7.365 |
| 12:34 ET | 965 | 7.35 |
| 12:36 ET | 200 | 7.35 |
| 12:38 ET | 900 | 7.3599 |
| 12:39 ET | 507 | 7.355 |
| 12:41 ET | 3604 | 7.365 |
| 12:43 ET | 200 | 7.36 |
| 12:45 ET | 200 | 7.345 |
| 12:48 ET | 500 | 7.315 |
| 12:50 ET | 200 | 7.315 |
| 12:52 ET | 300 | 7.3 |
| 12:54 ET | 600 | 7.305 |
| 12:56 ET | 100 | 7.305 |
| 12:59 ET | 200 | 7.28 |
| 01:03 ET | 1518 | 7.285 |
| 01:06 ET | 400 | 7.29 |
| 01:08 ET | 170 | 7.29 |
| 01:10 ET | 4099 | 7.31 |
| 01:12 ET | 400 | 7.3 |
| 01:14 ET | 730 | 7.295 |
| 01:15 ET | 200 | 7.29 |
| 01:17 ET | 1100 | 7.28 |
| 01:19 ET | 1104 | 7.285 |
| 01:21 ET | 908 | 7.28 |
| 01:24 ET | 300 | 7.275 |
| 01:26 ET | 4394 | 7.2633 |
| 01:28 ET | 3743 | 7.25 |
| 01:30 ET | 5595 | 7.27 |
| 01:32 ET | 3579 | 7.275 |
| 01:33 ET | 100 | 7.27 |
| 01:35 ET | 200 | 7.275 |
| 01:37 ET | 1222 | 7.285 |
| 01:39 ET | 4351 | 7.3 |
| 01:42 ET | 200 | 7.3 |
| 01:44 ET | 1344 | 7.3 |
| 01:46 ET | 400 | 7.31 |
| 01:48 ET | 176 | 7.31 |
| 01:50 ET | 552 | 7.3 |
| 01:51 ET | 400 | 7.295 |
| 01:53 ET | 832 | 7.285 |
| 01:55 ET | 1400 | 7.3 |
| 01:57 ET | 400 | 7.31 |
| 02:00 ET | 500 | 7.33 |
| 02:02 ET | 666 | 7.3214 |
| 02:04 ET | 409 | 7.31 |
| 02:06 ET | 200 | 7.315 |
| 02:08 ET | 300 | 7.31 |
| 02:09 ET | 696 | 7.32 |
| 02:11 ET | 200 | 7.325 |
| 02:13 ET | 1395 | 7.33 |
| 02:15 ET | 922 | 7.32 |
| 02:18 ET | 400 | 7.3 |
| 02:20 ET | 500 | 7.3 |
| 02:22 ET | 2299 | 7.3 |
| 02:24 ET | 220 | 7.31 |
| 02:26 ET | 200 | 7.31 |
| 02:27 ET | 800 | 7.3 |
| 02:29 ET | 200 | 7.3 |
| 02:33 ET | 552 | 7.3 |
| 02:36 ET | 5100 | 7.305 |
| 02:38 ET | 1900 | 7.295 |
| 02:40 ET | 1204 | 7.305 |
| 02:42 ET | 800 | 7.31 |
| 02:44 ET | 200 | 7.3 |
| 02:45 ET | 200 | 7.29 |
| 02:47 ET | 3772 | 7.31 |
| 02:49 ET | 1907 | 7.315 |
| 02:51 ET | 450 | 7.305 |
| 02:54 ET | 100 | 7.305 |
| 02:56 ET | 300 | 7.305 |
| 02:58 ET | 336 | 7.301 |
| 03:00 ET | 518 | 7.315 |
| 03:02 ET | 300 | 7.31 |
| 03:03 ET | 1400 | 7.33 |
| 03:05 ET | 678 | 7.33 |
| 03:07 ET | 128 | 7.325 |
| 03:12 ET | 300 | 7.325 |
| 03:14 ET | 935 | 7.32 |
| 03:16 ET | 2200 | 7.325 |
| 03:18 ET | 1234 | 7.315 |
| 03:20 ET | 900 | 7.325 |
| 03:21 ET | 200 | 7.329 |
| 03:23 ET | 300 | 7.325 |
| 03:25 ET | 300 | 7.325 |
| 03:27 ET | 2590 | 7.34 |
| 03:30 ET | 100 | 7.34 |
| 03:32 ET | 1605 | 7.33 |
| 03:34 ET | 500 | 7.32 |
| 03:36 ET | 3999 | 7.315 |
| 03:38 ET | 300 | 7.315 |
| 03:39 ET | 4507 | 7.32 |
| 03:41 ET | 1323 | 7.31 |
| 03:43 ET | 300 | 7.31 |
| 03:45 ET | 500 | 7.31 |
| 03:48 ET | 900 | 7.315 |
| 03:50 ET | 500 | 7.32 |
| 03:52 ET | 3097 | 7.305 |
| 03:54 ET | 1200 | 7.31 |
| 03:56 ET | 12606 | 7.305 |
| 03:57 ET | 9972 | 7.325 |
| 03:59 ET | 192635 | 7.34 |
Oct 3, 2024
Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference, from 4:00PM ET on Thursday Oct 03, 2024 by Dow Jones
4:00PM ET on Thursday Oct 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.0B | -2.1x | --- |
Prothena Corporation PLC | 902.4M | -16.6x | --- |
Zymeworks Inc | 912.2M | -8.4x | --- |
Immatics NV | 963.5M | -10.3x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -4.5x | --- |
Gyre Therapeutics Inc | 1.2B | -14.3x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Chief Financial Officer, Executive Vice President
- Jason O'byrne
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 12.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
